The FDA is elevating a recall of certain Philips imaging systems, due to a risk of the scanner’s hardware possibly falling onto the patient after the failure of one of its components. The agency ...
The U.S. FDA reported Feb. 15 that Philips USA, a subsidiary of Amsterdam-based Royal Philips NV, recalled three models of the Brightview line of single photon emission CT (SPECT) systems due to an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback